UASt regulatory sequences drive expression of an inverted repeat.
Expression of aptGD1367 under the control of Scer\GAL4Bx-MS1096 leads to a decrease in the size of the adult wing, and reduces the area between vein L3 and vein L4 as a percentage of the whole wing area, as compared to controls.
Wing discs expressing aptGD1367 under the control of Scer\GAL4ap-md544 exhibit growth disadvantage as evidenced by a significant decrease in size as compared to controls.
Flies expressing aptGD1367 under the control of Scer\GAL4elav-C155 (in the presence of Dcr-2Scer\UAS.cDa to enhance RNAi efficiency) show a significant reduction in ethanol sedation sensitivity compared to wild type. Using the temperature sensitive Scer\GAL80ts.αTub84B allele to restrict expression to a specific stage demonstrates that a decrease in ethanol sedation sensitivity is seen both when expression is restricted to metamorphosis and also when it is restricted to days 3-7 of adulthood.
Flies expressing aptGD1367 under the control of Scer\GAL4Crz.PU (in the presence of Dcr-2Scer\UAS.cDa to enhance RNAi efficiency) show a significant reduction in ethanol sedation sensitivity compared to wild type.
Adults expressing aptGD1367 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression under the control of Scer\GAL4Mef2.PR results in early pupal lethality.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 80-90% of the Scer\GAL4pnr-MD237-expressing area of the notum.
aptGD1367/Scer\GAL4Bx-MS1096 is an enhancer of visible phenotype of Scer\GAL4Bx-MS1096, smoPKA12.UAS
aptGD1367/Scer\GAL4Bx-MS1096 is an enhancer of wing phenotype of Scer\GAL4Bx-MS1096, smoPKA12.UAS
Co-expression of aptGD1367 enhances the fused wing phenotype of flies expressing smoPKA12.Scer\UAS under the control of Scer\GAL4Bx-MS1096.